[Hemodynamic effects of midazolam and flunitrazepam used as induction agents in cardiac patients].
D000328:Adult; D000771:Anesthesia, Intravenous / Q000379:methods; D000777:Anesthetics / Q000494:pharmacology*; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology*; D006328:Cardiac Catheterization; D005260:Female; D005445:Flunitrazepam / Q000494:pharmacology*; D006331:Heart Diseases / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008874:Midazolam; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects*
D000777:Anesthetics; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D005445:Flunitrazepam; D008874:Midazolam
Retentissement hémodynamique du midazolam et du flunitrazépam utilisés comme agents d'induction chez le cardiaque.